At Survon, we're transforming healthcare through intelligent data-driven solutions. Our AI-powered platform bridges diagnostics and digital health records, transforming complex medical information into actionable insights. Starting with oncology, we help healthcare providers and patients make more precise, personalized decisions that improve patient outcomes and optimize clinical resources.Born from Harvard's innovation ecosystem and supported by Mayo Clinic Accelerator, we're turning data into a powerful tool for more intelligent, patient-centered care.We are proud to be selected as a finalist in the Harvard Business School New Venture Competition 2020 and are honored to have received the Best Social Impact Award for our dedication to helping cancer patients.I welcome patients, medical professionals, and laboratories who share our passion for advancing cancer research and improving patient outcomes to reach out and explore potential partnerships with us.Company journey:Pre-COVID (2018 - 2020):- Founded at Harvard.- Finalist and Best Social Impact Award Winner at HBS New Venture Competition.- Initial development of HIPAA-compliant imaging platform.Post-COVID (2023 - Present):- Relaunched with refined focus on clinical intelligence.- Selected for Mayo Clinic Accelerator Program.- Welcomed Mayo Clinic as an investor.- Developing AI-powered HIPAA-compliant clinical decision support platform.

• SG Entrepreneurs Think Tank, National Institute of Education (NIE), SingaporeMar 2017 - Present | Singapore• American Society for Testing & Materials (ASTM International)Jan 2017 - Present | United StatesCommittee Member for F04 (Medical and Surgical Materials and Devices) and F42 (Additive Manufacturing Technologies).• National ISO Mirror Working GroupOct 2016 - Present | SingaporeCommittee member for ISO/TC 150 (Implants for surgery) and 194 (Biological and clinical evaluation of medical devices).• Biomedical Standards Committee, SMF SDO, Enterprise SingaporeJan 2015 - Present | Singapore• Bioengineering Technical Committee, Institution of Engineers Singapore (IES)May 2013 - Present | Singapore

Developed and delivered educational programs for individuals including students, post-graduates, and professionals in areas such as Fintech, Artificial Intelligence, Machine Learning, Innovation, Business, and Entrepreneurship.

In my capacity as an Entrepreneur-in-Residence (EIR) at Innoforce, my responsibilities revolve around identifying exceptional companies with compelling technologies and talented teams for potential investment, acquisition, partnership, and licensing opportunities.Being an integral member of a team managing a USD$50M fund, my daily tasks involve engaging with founders and corporate executives, assessing prospective companies and conducting thorough due diligence, formulating comprehensive business cases, and delivering presentations to senior management at Innoforce.

Advisory Board Member of College of Science.

Emcero, formerly named Bio3D Technologies, was a deep-tech enterprise that centered its efforts on the practical application of cutting-edge technologies. The company's objective was to connect innovative ideas to real-world applications and bring these technologies to market.The renowned innovation we developed, the 3D bioprinting platform, was ultimately licensed to a US-based company for their internal research purposes. In part of the agreement, I continued my involvement as a consultant.

Bio3D Technologies developed the world's first true scientific 3D printing platform, revolutionizing research and biomedical applications.Bio3D received an invitation from the Tokyo Stock Exchange to list on MOTHERS, which is the market for high-growth and emerging stocks. As part of the listing process, the company underwent a rebranding initiative and emerged as "Emcero".

Novi Biotech, established in 2010, was the foremost company in Singapore specializing in nano-biotechnology. The company was dedicated to researching and developing the applications and technologies of Raman Spectroscopy and Surface Enhanced Raman Spectroscopy (SERS) to detect and measure a variety of substances, such as proteins, drugs, chemicals, genes, bacteria, poisons, and pesticides. Novi Biotech created two advanced, patent-pending technology platforms that can detect and measure multiple disease markers with minimal effort, time, and hassle.

metaGenes Pte Ltd focused primarily on delivering technological solutions, including software and web design services. In addition to its core business, metaGenes also engaged in diverse technology projects, such as the development of the High-Altitude Imaging System and web search technologies, among others.

My first business providing web and email hosting services, web designing, and software programming. First app written was a scientific calculator in VB6.